Jaguar Health
JAGX----
Jaguar Health (JAGX)
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointe...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Jaguar Health Analyst Rating
View MoreForecast & Rating
Feb 12, 2026Price forecast
$262.5025385.46%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · 1 day ago, 08:02 AM
Jaguar Health announces press release on crofelemer compassionate use for infant MVID patient in EU
- Price Alert · 1 day ago, 06:52 AM
Pre-market hot trades in US stocks: Jaguar Health up 12.70% in pre-market; Sterling Infrastructure down 3.51% in pre-market
- Price Alert · Jul 17 at 06:17 AM
Pre-market hot trades in US stocks: Jaguar Health up 5.62% pre-market; Arm down 3.24% pre-market
- TradingView · Jul 14 at 03:23 PM
Jaguar Health Extends Crofelemer Supply With Alivus Through 2029, Adds Minimum Purchase Commitments
- PUBT · Jul 14 at 03:17 PM
Jaguar Health signs new crofelemer manufacturing, supply deal with Alivus through March 2029
- PUBT · Jul 1 at 03:34 PM
Jaguar Health completes Series O preferred conversion into common shares at 3.209-to-1 ratio
